Lyka Labs Clarifies No Material Events Behind Recent Share Price Movement

1 min read     Updated on 09 Apr 2026, 09:37 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Lyka Labs Limited responded to BSE's inquiry about recent share price movement on April 9, 2026, clarifying that no material information or events requiring disclosure under SEBI regulations are behind the price changes. The company emphasized its regular compliance with listing obligations and timely disclosure practices, with the communication officially authorized by Company Secretary Shailendra Kumar Agrawal.

powered bylight_fuzz_icon
37296455

*this image is generated using AI for illustrative purposes only.

Lyka labs Limited has issued a clarification to BSE Limited regarding the recent significant movement in its share price, stating that no undisclosed material events are behind the price changes. The pharmaceutical company responded to a BSE inquiry dated April 8, 2026, through a formal communication on April 9, 2026.

Company's Response to Exchange Inquiry

In its disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lyka Labs clarified that there are no material information or material events that required disclosure or announcement by the company. The management stated that in their opinion, no undisclosed events have a bearing on the movement in the price of the company's security.

Parameter: Details
Communication Date: April 9, 2026
BSE Script Code: 500259
Reference Number: L/SURV/ONL/PV/APJ/2026-2027/3565
Regulation: SEBI Regulation 30

Regulatory Compliance Statement

Lyka Labs emphasized its commitment to regulatory compliance, noting that the company has been regularly disseminating relevant information and details from time to time whenever required. The company stated it remains in full compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, ensuring timely disclosure of material events to investors and exchanges.

Official Authorization

The clarification was officially signed by Shailendra Kumar Agrawal, Company Secretary and Compliance Officer, from Mumbai. The digital signature was authenticated on April 9, 2026, at 11:01:02 +05'30', confirming the official nature of the communication to the exchange.

This type of clarification is standard practice when exchanges seek explanations for unusual price movements in listed securities, ensuring market transparency and investor protection.

Historical Stock Returns for Lyka Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%+4.54%+1.72%-38.40%-44.01%+112.25%

What external market factors or sector-wide developments could be driving the unexplained price volatility in Lyka Labs' shares?

Will BSE or SEBI initiate further surveillance measures or investigations into the trading patterns of Lyka Labs following this clarification?

How might this price movement without disclosed material events impact investor confidence in Lyka Labs' transparency going forward?

Lyka Labs Limited Submits SEBI Compliance Certificate for Q4 FY26

1 min read     Updated on 07 Apr 2026, 03:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Lyka Labs Limited filed its quarterly SEBI compliance certificate for Q4 FY26 on 7th April, 2026, covering the quarter ended 31st March, 2026. The certificate, submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirms proper dematerialisation processes. MUFG Intime India Private Limited, the company's registrar, verified that all securities received for dematerialisation were processed within prescribed timelines and regulatory requirements were met.

powered bylight_fuzz_icon
37100163

*this image is generated using AI for illustrative purposes only.

Lyka Labs Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company filed the mandatory certificate for the quarter ended 31st March, 2026, demonstrating adherence to dematerialisation compliance standards.

Regulatory Filing Details

The company submitted the certificate on 7th April, 2026, to both major stock exchanges where its shares are listed. Company Secretary Shailendra Kumar Agrawal signed the submission, ensuring proper corporate governance protocols were followed.

Exchange Details: Information
BSE Scrip Code: 500259
NSE Scrip Code: LYKALABS
Filing Date: 7th April, 2026
Quarter Covered: Q4 FY26 (ended 31st March, 2026)

Registrar Confirmation

MUFG Intime India Private Limited (formerly Link Intime India Private Limited) served as the registrar and share transfer agent, providing the underlying certificate. The registrar confirmed that all securities received from depository participants for dematerialisation during Q4 FY26 were properly processed.

Key confirmations from the registrar included:

  • All securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
  • Security certificates were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners
  • Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed

Compliance Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 requires companies to submit quarterly certificates confirming proper handling of dematerialisation processes. This regulation ensures transparency in the conversion of physical securities to electronic form and maintains investor protection standards.

Regulatory Parameters: Details
Regulation: SEBI (Depositories and Participants) Regulations, 2018
Specific Section: Regulation 74(5)
Reporting Frequency: Quarterly
Registrar: MUFG Intime India Private Limited

The filing represents routine compliance activity, demonstrating the company's commitment to maintaining regulatory standards and ensuring proper handling of shareholder securities through authorised depositories and participants.

Historical Stock Returns for Lyka Labs

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%+4.54%+1.72%-38.40%-44.01%+112.25%

How might the transition from Link Intime to MUFG Intime as registrar impact Lyka Labs' future shareholder services and operational efficiency?

What potential regulatory changes could SEBI introduce that might affect dematerialisation compliance requirements for pharmaceutical companies?

Will Lyka Labs consider expanding its stock exchange listings beyond BSE and NSE to attract more institutional investors?

More News on Lyka Labs

1 Year Returns:-44.01%